Recent share performance and business snapshot
W. R. Berkley (WRB) has seen recent share pressure, with the stock showing negative returns over the past week, month, and past 3 months. Its 1 year and multi year total returns remain positive.
The commercial insurer reports revenue of US$14,707.856m and net income of US$1,779.403m. Annual revenue growth is 0.40% and net income growth is 2.62%, supported by operations across Insurance and Reinsurance & Monoline Excess segments.
See our latest analysis for W. R. Berkley.
The share price at US$64.49 reflects recent pressure, with a 9.17% 1 month share price return decline. Longer term total shareholder returns of 1.49% over 1 year and 116.89% over 5 years remain positive, suggesting momentum has recently faded after a stronger multi year run.
If this kind of insurance exposure feels concentrated, it can help to widen your watchlist and scan 20 top founder-led companies
With WRB trading at US$64.49, sitting below the average analyst price target and with a high intrinsic discount flag, the real question is whether you are seeing mispricing here or whether the market is calmly baking in future growth.
Most Popular Narrative: 5.6% Undervalued
At $64.49, W. R. Berkley sits below the narrative fair value of $68.33. That gap rests on detailed assumptions around margins, earnings and the P/E it could support.
The expanding complexity of global business and assets is driving strong demand for specialty insurance solutions, with record net written premiums and broad-based growth across all lines positioning W. R. Berkley to continue increasing revenue.
W. R. Berkley Future Earnings and Revenue Growth Read the complete narrative.
Want to see what underpins that fair value gap? The narrative leans on steady revenue, firmer profit margins and a future earnings multiple above the wider insurance group. The exact mix of those inputs is where the valuation story becomes particularly important.
Result: Fair Value of $68.33 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on pricing and loss trends. Softer commercial and reinsurance pricing or higher inflation-driven claims are both capable of undercutting the current valuation story.
Find out about the key risks to this W. R. Berkley narrative.
Another angle on valuation
The narrative fair value of $68.33 suggests W. R. Berkley is 5.6% undervalued at $64.49, yet its 13.6x P/E sits above the US Insurance group on 10.8x, peers on 11x, and even a 12.4x fair ratio. That richer multiple can mean less room for error if the story shifts.
To see what the numbers say about this price, check the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed signals across valuation, recent returns, and the business outlook, it helps to move fast, test the numbers, and reach your own view using the 2 key rewards and 1 important warning sign.
Looking for more investment ideas?
If you stop your research with a single stock, you risk missing opportunities that might fit your goals even better, so keep expanding your idea list.
- Target quality at a discount by scanning 55 high quality undervalued stocks that balance solid fundamentals with pricing that may not fully reflect their strengths.
- Prioritise resilience by checking 75 resilient stocks with low risk scores that score well on stability, risk indicators, and balance sheet strength.
- Spot potential early movers by reviewing the 29 elite penny stocks with strong financials that combine smaller size with stronger financial profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com